Lisata TherapeuticsLSTA
13F holders, Q2 2025 (June 30)20holders −2
2new positions
3sold out
1famous investor
$2.89avg. 13F price*
At the end of Q2 2025, 20 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings, down 2 from Q1 2025. 2 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($732K), BML Capital Management, LLC ($608K) and Renaissance Technologies ($298K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lisata Therapeutics Inc.
- CUSIP
- 128058302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $32K |
| Exits | 3 | $38 |
All 13F filers, Q1 2025 → Q2 2025: 20,489 shares bought and 9,181 shares sold, net +11,308 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | No change | 254,182 | $732K |
| BML Capital Management, LLC | 0.47% | Reduce -3.3% | 209,814 | $608K |
| Renaissance Technologies | 0.00% | Add +0.1% | 102,822 | $298K |
| Geode Capital Management, LLC | 0.00% | Add +0.9% | 61,082 | $176K |
| BlackRock, Inc. | 0.00% | No change | 54,857 | $159K |
| Dimensional Fund Advisors LP | 0.00% | Add +2.3% | 25,793 | $74K |
| State Street Corp. | 0.00% | No change | 14,348 | $41K |
| Cerity Partners LLC | 0.00% | New | 12,183 | $32K |
| Bank of America Corp. | 0.00% | Add +0.1% | 10,421 | $30K |
| Northern Trust Corp. | 0.00% | No change | 10,268 | $30K |
| HighTower Advisors, LLC | 0.00% | No change | 10,042 | $29K |
| UBS Group AG | 0.00% | Add +706800.0% | 7,069 | $20K |
| Royal Bank of Canada | 0.00% | No change | 5,912 | $17K |
| Founders Capital Management | 0.00% | No change | 2,000 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -40.0% | 1,323 | $4K |
| Morgan Stanley | 0.00% | Reduce -84.7% | 224 | $649 |
| SBI Securities Co., Ltd. | 0.00% | No change | 140 | $406 |
| Raymond James Financial Inc. | 0.00% | New | 6 | $17 |
| Barclays PLC | 0.00% | No change | 4 | $12 |
| Cheviot Value Management, LLC | 0.00% | No change | 3 | $8 |
"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.